Low-Dose Naltrexone Shows No Significant Pain Relief in Fibromyalgia Trial Jacinthlyn Sylvia21 April 2025 8:45 PM ISTA new study published in the journal of CNS Drugs showed that low-dose naltrexone (LDN) did not outperform placebo in reducing pain intensity or...
Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes Dr. Nandita Mohan25 May 2022 5:45 PM ISTCNS Drugs journal brought out the study that aimed to assess whether antipsychotic use during pregnancy is associated with gestational diabetes and...
Indian Pharma Market sees significant revival in March 2021, registers 10.3 percent growth: AIOCD-AWACS Report Medical Dialogues Team25 April 2021 11:45 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant revival with a rise of 10.3 per cent for the month of March 2021,...
